tion. IVUS extends a measure of quality control that directs optimal balloon and stent sizing. Adjunctive IVUS use identifies suboptimal initial stent expansion and guides additional balloon angioplasty. Use of IVUS does not increase neurologic events. IVUS should be considered an important component of advanced endovascular procedures such as CAS.
Objective: Carotid artery stenting (CAS) is accepted as an alternative to carotid endarterectomy for high-risk patients with significant carotid occlusive disease. A rare complication of this approach is stent fracture. The incidence and clinical significance of carotid stent fractures are not well studied. To better understand the incidence of stent fracture and to assess whether fracture is associated with in-stent restenosis, we provide this update to our prospectively evaluated CAS patients.
Methods: Our study population includes patients who underwent CAS between January 2002 and December 2017. Patients were consented and prospectively evaluated for stent fractures by anteroposterior and lateral cervical radiographs. All fractured stents were examined by duplex ultrasound at 1 month, 6 months, and annually thereafter, with a minimum 2-year follow-up. The fracture prevalence was then calculated as a percentage of the total number of stents placed. A subset of these patients had a second radiograph 1 to 6 years after the initial radiograph to assess for late fracture development.
Results: A total of 181 patients with 206 stents have been evaluated to date, with 24 fractures identified for a fracture incidence of 11.7% during the course of our study. Of the 206 stents, 95 stents were also evaluated with a second radiograph between 1 and 6 years later, identifying 7 late stent fractures with a late fracture rate of 8.1%. Of the 24 patients with carotid stent fractures, 2 patients developed in-stent restenosis, of whom only one required reintervention.
Conclusions: Carotid artery stent fracture occurs at the rate of 11.7%. Furthermore, late stent fractures have also been identified. Currently, there is not an accepted protocol to assess for stent fractures, nor have there been morbidities identified with stent fractures. Given the significant incidence of stent fracture identified in this study, we recommend further prospective study to confirm the incidence of carotid stent fracture and to assess the relative risk of in-stent restenosis of fractured stents.
Author Disclosures: T. Carle: Nothing to disclose; N. Karani: Nothing to disclose; R. Molnar: Nothing to disclose; J. L. Williams: Nothing to disclose. Methods: From January 1996 to December 2017, there were 6636 consecutive CEAs performed. Data concerning these interventions were prospectively collected in a dedicated database. A post hoc analysis of the database was performed, and 4379 interventions performed in asymptomatic patients were found and divided in two subgroups: patients operated on between 1996 and 1999 (1321 interventions, group 1); and patients operated on between 2013 and 2017 (1179 interventions, group 2). The two groups were compared in terms of preoperative characteristics, surgery and anesthesia techniques, and perioperative results with two tests.
IP115.

Refinements in Surgical and
Results: Patients in group 2 were older than patients in group 1 and more frequently had severe cardiovascular comorbidities. There were no differences between the two groups in terms of degree of stenosis at the side operated on and status of the contralateral carotid artery. All the interventions in group 1 were performed under general anesthesia (GA) with selective shunt insertion on the basis of somatosensory evoked potential monitoring; in group 2, the corresponding figure was 14% (P < .001), whereas the remaining 1015 patients had remifentanil anesthesia with selective shunt insertion on the basis of clinical monitoring. Shunt insertion rates were 9.4% in group 1 and 13.8% in group 2 (P < .001). The frequency of primary closures fell from 39.5% in group 1 to 2.7% in group 2 (P < .001), whereas there was an increase in patch closure in group 2 (from 48% to 94%). Perioperative mortality was 0.4% in group 1 and 0.5% in group 2 (P ¼ .7), whereas perioperative stroke rate was 1% in group 1 and 0.25% in group 2 (P ¼ .01). Thirty-day stroke and death rates were 1.45% and 0.7%, respectively (P ¼ .01). The corresponding values in patients with GA without patch, with GA with patch, and with clinical monitoring with patch were 1.8%, 1.3%, and 0.5%, respectively (P ¼ 0.05). At univariate analysis, the avoidance of shunt, use of patch, and clinical monitoring significantly improved 30-day outcomes; at multivariate analysis, only the avoidance of shunt maintained its significant value (odds ratio, 4.7; 95% confidence interval, 1.7-12.8; P ¼ .002).
Conclusions: The introduction and wide diffusion in our experience of patch closure and remifentanil anesthesia with clinical monitoring allowed significant improvement of the perioperative results of CEA in the last two decades in asymptomatic patients.
Author Disclosures: A. Alessi Innocenti: Nothing to disclose; G. Bassoli: Nothing to disclose; E. Chiti: Nothing to disclose; F. Ciappi: Nothing to disclose; W. Dorigo: Nothing to disclose; F. Masciello: Nothing to disclose; C. Pratesi: Nothing to disclose; S. Speziali: Nothing to disclose. Objective: The role of the carotid plaque fibrous cap in carotid-related stroke risk has been demonstrated in many studies. The aim of this study was to evaluate the relationship between the presence of a carotid plaque ulcer and the perioperative complication risk in a consecutive series/cohort of patients submitted to carotid endarterectomy (CEA) at our academic tertiary hospital.
IP117. Perioperative Complication Risk Prediction
Methods: A retrospective review of a prospectively collected database on consecutive CEAs performed between January 2009 and December 2017 was performed. All patients with a carotid plaque ulcer (defined as a discontinuation in the carotid fibrous cap of >2 mm) at carotid duplex ultrasound were analyzed. Perioperative (30-day) complications considered for analysis were TIA, minor and major stroke, death, myocardial infarction, hemodynamic instability, cervical hematoma, and cranial nerve palsy. The prognostic value of plaque ulcer on the development of perioperative complications was assessed by odds ratio (OR) estimation.
Results: Among 964 CEAs, 158 were performed in symptomatic patients and 806 in asymptomatic patients. A carotid plaque ulcer was detected in 207 patients. Complications are reported in the 
Conclusions:
The presence of a carotid plaque ulcer is significantly associated with the presence of preoperative carotid-related neurologic symptoms, but it is not able to predict an increase in neurologic or total complications in a consecutive series of symptomatic and asymptomatic patients submitted to CEA.
Author Disclosures: V. Baldassarre: Nothing to disclose; L. Capoccia: Nothing to disclose; M. Formiconi: Nothing to disclose; W. Mansour: Nothing to disclose; M. Panico: Nothing to disclose; E. Sbarigia: Nothing to disclose; P. Sirignano: Nothing to disclose; F. Speziale: Nothing to disclose.
IP119.
Early and Long-Term Results of Viabahn Endograft for Treatment of Supra-Aortic Trunk Aneurysm* Paola Wiesel, Domenico Angiletta, Giovanni Mastrangelo, Cristina Galeandro, Raffaele Pulli. University of Bari, Bari, Italy
Objective: The objective of this study was to evaluate early and longterm results of the Viabahn endograft (W. L. Gore & Associates, Flagstaff, Ariz) in the treatment of supra-aortic trunk (SAT) aneurysm.
Methods: A retrospective study from 2009 to 2017 was conducted in our institution. Thirteen patients matched the inclusion criteria in the indexed period. Patients' characteristics and early and long-term results were recorded in a dedicated database.
Results: A total of 13 SAT aneurysms (3 female and 10 male patients) were treated: 8 of the subclavian artery, 2 of the internal carotid artery, 2 of the common carotid artery, and 1 of the vertebral artery. The cause was post-traumatic in four cases (30%), related to vasculitis in two (15%), and atherosclerotic in seven (55%). Indication for surgical treatment was dimension and presence of symptoms. Four patients (30%) experienced compression symptoms, six (46%) were treated in an emergency setting (three for pain and three for rupture), and three patients (24%) were asymptomatic. All the subclavian artery aneurysms were treated through a surgical exposure of the ipsilateral brachial artery; in the remaining patients, a percutaneous femoral approach was performed (38%). Technical success was 100%, and no early complications were recorded. In all cases, postoperative therapy consisted of dual antiplatelet therapy (clopidogrel 75 mg and aspirin 100 mg) for 6 months followed by a single antiplatelet drug (aspirin 100 mg). Mean follow-up was 3.5 years (0-8 years). We performed a duplex ultrasound scan of the SAT at 1 month, 6 months, and 12 months and then every year. Primary patency was 100%; one patient had an asymptomatic occlusion of the subclavian endograft after 4 years, whereas all the other endografts were patent at the last follow-up. No cranial nerve injuries were reported, and stroke-free survival rate was 100%. No aneurysm-related death occurred. One patient died after 3 years of pulmonary cancer.
Conclusions: The Viabahn graft, even if it is considered off-label for the treatment of SAT aneurysms, provided, in our experience, acceptable early and long-term results because of its conformability and flexibility. In our opinion, the endovascular approach with this type of stent graft is technically feasible with low complication rates.
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Early Carotid Endarterectomy in Symptomatic Patients* Cristina Galeandro, Domenico Angiletta, Paola Wiesel, Marco Petruzzellis, Raffaele Pulli. University of Bari, Bari, Italy
Objective: The objective of this study was to evaluate whether early carotid endarterectomy (CEA) in symptomatic patients is associated with higher rates of stroke or death in the postoperative period.
Methods: A retrospective study from 2016 to 2017 was conducted in our institution. In the indexed period, 68 patients matched the inclusion criteria. Patients' characteristics and results were recorded in a dedicated database. All patients were submitted to a preoperative and postoperative clinical examination by an independent neurologist and were divided into four groups based on the surgical timing (0-7 days; 7-15 days; 15-30 days; >30 days). National Institutes of Health Stroke Scale score was also calculated in all cases. In all patients, the level of serologic and intraplaque ST2 (suppression of tumorigenicity) was evaluated as a potential marker of plaque instability. Data were analyzed with c 2 test and Kaplan-Meier curves (SPSS 24.0 statistical software; IBM Corp, Armonk, NY).
Results: Of 68 patients treated, 47 were male (69%), with a median age of 70 years (range, 48-83 years); 82% suffered from hypertension, and 29% were diabetic patients. Preoperative symptoms consisted of transient ischemic attack (43%), minor stroke (32%), major stroke (23%), and crescendo transient ischemic attack (2%). Degree of stenosis was between 60% and 80% in 63% of the patients, between 80% and 99% in 27%, and near occlusion in 10%. CEA was performed in 100% of cases with a National Institutes of Health Stroke Scale score between 0 and 8: 8 (12%) eversion CEAs and 60 (88%) CEAs with patch. Eleven patients (16%) were treated within 7 days; 24 (35%) were assigned to the second group (7-15 days), 12 (18%) to the third group (15-30 days), and 21 (31%) to fourth group. No neurologic events or deaths were recorded at 30 days. There was no statistical difference between the four groups regarding ST2 marker levels. In the median follow-up of 12 months (range, 1-24 months), stroke-free survival rate was 100%.
Conclusions: The time between neurologic event and CEA did not influence the early and midterm results in our series. Early CEA may be safely proposed also in patients with major stroke.
